Publications in collaboration with researchers from Hospital Clinic Barcelona (17)

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  2. Silver jubilee: 25 years of the first demonstration of the direct effect of phosphate on the parathyroid cell

    Nefrologia, Vol. 42, Núm. 6, pp. 645-655

2019

  1. Inhibition of the mTOR pathway: A new mechanism of β cell toxicity induced by tacrolimus

    American Journal of Transplantation, Vol. 19, Núm. 12, pp. 3240-3249

2016

  1. Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study)

    Nefrologia, Vol. 36, Núm. 3, pp. 255-267

  2. mTOR Inhibition: Reduced Insulin Secretion and Sensitivity in a Rat Model of Metabolic Syndrome

    Transplantation Direct, Vol. 2, Núm. 2, pp. E65

2012

  1. Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus

    Molecular Genetics and Metabolism, Vol. 105, Núm. 3, pp. 525-527

2011

  1. Erratum: Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes (Clinical Chemistry and Laboratory Medicine (2011) 49:5 (825-833))

    Clinical Chemistry and Laboratory Medicine

  2. KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients

    Clinical Transplantation, Vol. 25, Núm. 3

  3. Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes

    Clinical Chemistry and Laboratory Medicine, Vol. 49, Núm. 5, pp. 825-833

  4. Recommendations of the Spanish Society of Nephrology for managing bone-mineral metabolic alterations in chronic kidney disease patients (S.S.N.-MM)

    Nefrologia, Vol. 31, Núm. SUPPL.1, pp. 3-32

2009

  1. A novel risk score for mortality in renal transplant recipients beyond the first posttransplant year

    Transplantation, Vol. 88, Núm. 6, pp. 803-809

2008

  1. Unmasking glucose metabolism alterations in stable renal transplant recipients: A multicenter study

    Clinical Journal of the American Society of Nephrology, Vol. 3, Núm. 3, pp. 808-813

2007

  1. Impact of long-term therapy with FTY720 or mycophenolate mofetil on cardiac conduction and rhythm in stable adult renal transplant patients

    Transplantation, Vol. 83, Núm. 5, pp. 645-648

2006

  1. Presentation and role of transplantation in adult patients with type 1 primary hyperoxaluria and the I244T AGXT mutation: Single-center experience

    Kidney International, Vol. 70, Núm. 6, pp. 1115-1119

2004

  1. Análisis de factores de riesgo genéticos asociados a la nefropatía crónica del trasplante renal: Polimorfismos genéticos de citoquinas, moléculas de adhesión, sistema de coagulación-plaquetar y marcadores de riesgo cardiovascular

    Nefrologia, Vol. 24, Núm. SUPPL.4, pp. 49-56

2001

  1. Mujer de 24 años de edad, portadora de un trasplante renal, con pérdida de fuerza progresiva en las extremidades inferiores de 2 meses de evolución

    Medicina Clinica

2000

  1. Vitamin D receptor gene polymorphisms and bone mineral density in patients on hemodialysis

    Nephron